Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged Medicare beneficiaries.
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Diabetes and hypertension are the leading causes of renal failure. This study investigated racial differences in developing ESRD by participants' diabetes and hypertension status. This longitudinal study included 1,306,825 Medicare beneficiaries who were aged > or =66 yr at the study start and followed up to 10 yr from January 1, 1993, for the development of ESRD or death. During the 10 yr, 0.93 patients per 100 received ESRD treatment. After adjustment for age and gender, among patients with diabetes, black patients were 2.4 to 2.7 times and other races/ethnicities 1.6 to 1.7 times more likely than white patients to develop ESRD. Among hypertensive patients, black patients were 2.5 to 2.9 and others 1.7 to 1.8 times more likely than white patients to develop ESRD. Among patients with neither diabetes nor hypertension, black patients were 3.5 and others 2.0 times more likely. Black men with diabetes were 1.9 to 2.1 and women 2.5 to 3.4 times more likely than their white counterparts to develop ESRD. Hypertensive black men were 2.1 to 2.2 and women 2.8 to 3.6 times more likely to develop ESRD. The same findings were noted in women of other races/ethnicities. Compared with white counterparts, mortality was higher for black patients in all cohorts but lower among patients with ESRD. Although they are leading causes for renal failure, diabetes and hypertension do not cause racial differences in developing ESRD. Minority women especially are at greater risk for ESRD than white women. Further studies are needed to determine whether earlier initiation of dialysis is a factor in higher ESRD incidence among minorities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Black patients have a disproportionately higher burden of cardiovascular and advanced kidney disease.12,13,14,15,16,17,18,19,20”
From Association of race/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US (2021) · cites this paper as [14]
Citations
Cites
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
Kuczmarski, R. J. (1994) · JAMA · doi:10.1001/jama.272.3.205 · Cited by 2,362
Logistic Regression Using the SAS System : Theory and Application
Allison, P. D. (1999) · Cited by 2,087
Weiner, D. E., Tighiouart, H., Amin, M. G., Stark, P. C., MacLeod, B., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000123691.46138.e2 · Cited by 1,176 · cited 1×
“(27), analyzing large community-based cohort studies, reported significantly higher mortality in black patients with CKD than in white patients with CKD, further suggesting that survival of patients with CKD cannot explain higher ESRD incidence in black than white patients.”
BackgroundRule, A. D., Larson, T. S., Bergstralh, E. J., Slezak, J. M., Jacobsen, S. J., & Cosio, F. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-12-200412210-00009 · Cited by 1,066
Foley, R. N., Murray, A. M., Li, S., Herzog, C. A., McBean, A. M., Eggers, P. W., & Collins, A. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004030203 · Cited by 972
Self-citationMurray, C. J. L., Kulkarni, S. C., Michaud, C., Tomijima, N., Bulzacchelli, M. T., Iandiorio, T. J., & Ezzati, M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030260 · Cited by 762 · cited 2×
“Racial disparity in mortality and life expectancy in the United States did not change between 1982 and 2001, which cannot be explained by income or basic health care access and utilization factors alone (22).”
BackgroundResultDeaths: preliminary data for 2002.
Kochanek, K. D., & Smith, B. L. (2004) · PubMed · Cited by 700
Poggio, E. D., Wang, X., Greene, T., Van Lente, F., & Hall, P. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060447 · Cited by 644
Cited by
Items 101–117 of 117
Demographics of Kidney Disease
Anderson, A. H., Berns, J. S., Bleicher, M. B., & Feldman, H. I. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10020-x · Cited by 3
Genomic biomarkers for chronic kidney disease: the first step towards personalized medicine?
Cao, J.-Y., Zhou, L., & Liu, B. (2019) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2018.16 · Cited by 1
Cardiovascular disease prevention in a health insurance program in rural Nigeria
Hendriks, M. E. (2014) · UvA-DARE (University of Amsterdam) · Cited by 1
Brown, L. J. (2014) · Digital Archive @ GSU · doi:10.57709/6394272
Relationship of Race and Proteinuria to Renal Function Decline in Patients with CKD
Rosansky, S. J. (2014) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.1000168
“The majority of the reported data on relative risk of death in blacks versus whites with similar levels of renal function found no difference or a higher death rate in blacks versus whites [12-14].”
BackgroundLebov, J. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/says-3m06
Health Disparities in Nephrology
Powe, N. R., & Peralta, C. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10085-5
Okafor, U. H., Uzoh, R., & Samuel, E. (2020) · International Journal of Nephrology and Kidney Failure · doi:10.16966/2380-5498.201
“The impact is even more significant for developing countries that face the double burden of infectious diseases and growing problem of non-communicable diseases [8,9].”
BackgroundGust, C. J., Bryan, A. D., Havranek, E. P., Vupputuri, S. X., Steiner, J. F., Blair, I. V., Hanratty, R. L., & Daugherty, S. L. (2022) · Race and Social Problems · doi:10.1007/s12552-022-09359-2 · Cited by 1
“Poorer BP control in minority groups contributes to a higher incidence of end stage renal disease and cardiovascular disease (Graham, 2015; Veazie et al., 2014; Xue et al., 2007).”
BackgroundA Retrospective Study of Research Data on End Stage Renal Disease
Ponnaluri, S., & King, M. J. (2016) · Journal of Emerging Investigators · doi:10.59720/15-056
Biochemical Assessment of Chronic Kidney Disease in Iraq Patients
Abbas, Z. A. K., & Al-Salihi, Z. S. A. (2024) · Academic International Journal of Medical Sciences · doi:10.59675/m214
“This should be taken into account because adult Iraqis experience a high prevalence of chronic health issues [39].”
Kidney disease and complementary medicine
Dogodzi, F. K., Enyetornye, B., Acheampong, O. D., & Osei, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33090-2.00008-4
Breeze, C. E., Batorsky, A., Lee, M. K., Szeto, M. D., Xu, X., McCartney, D. L., Jiang, R., Patki, A., Kramer, H. J., Eales, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14524683
Breeze, C. E., Batorsky, A., Lee, M. K., Szeto, M. D., Xu, X., McCartney, D. L., Jiang, R., Patki, A., Kramer, H. J., Eales, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14524686
Haritha, C. V., Kumawat, S., Madabhavi, P. M., Sharma, M., Sharma, A., Aneesha, V. A., Karikalan, M., Jadhav, S. E., Parida, S., Singh, T. U., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178533
Rochemont, D. R. (2019) · theses.fr (ABES) · doi:10.70675/7d48c3caz1d6bz4097z89d6zaa3aa5a1584c · Cited by 1
Horimoto, A. R. V. R., & Franceschini, N. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.26092
Metadata
- Authors
- Xue, J. L., Eggers, P. W., Agodoa, L. Y., Foley, R. N., & Collins, A. J.
- Affiliations
- University of Minnesota (US)
- National Institutes of Health (US)
- Corresponding author
- Xue, Jay L.
- Foley, Robert N.
- Collins, Allan J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-04
- Volume
- 18
- Issue
- 4
- Pages
- 1299-1306
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2027108122
- Cited by
- 117
- References
- 39
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 8 · 2021: 7 · 2020: 4 · 2019: 8 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 5 · 2014: 8 · 2013: 6 · 2012: 11
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (N01-DK-9-2343)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Social Sciences › Health › Health disparities and outcomes
- Keywords
- end-stage renal disease, racial disparities, ethnic differences, diabetes mellitus, hypertension, Medicare beneficiaries, older adults, Black patients, minority women, mortality, dialysis initiation, renal failure
- MeSH terms
- Aged, Aged, 80 and over, Female, Medicare, Humans, Kidney Failure, Chronic, Longitudinal Studies, Male, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.